Modified citrues pectins (MCP) fight cancer

MCP slows PSA doubling time. Patients who had either relapsed after or failed prior treatment for prostate cancer (PSA range 0.63 to 7.50) were given Modified Citrus Pectin (PectaSol ®, EcoNugenics, Inc., San Rafael, CA 94901) at a dosage of 15 grams per day in three divided oral doses. PSA doubling time was calculated.

A response (more than 30% lengthening of PSA doubling time) was seen in 4/7 patients (57%).

One patient (1/7) had a partial response, one patient (1/7) had stable disease, and one patient (1/7) did not respond.

Modified Citrus Pectin appears to lengthen the PSA doubling time in prostate cancer patients with low levels of PSA.